SCHEMBL6469689

SCHEMBL6469689

CCOC(=O)c1c(N)c(C(N)=O)nn1-c1ccc(Br)c(F)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.56
HPGD P15428 3/20 0.56
KDM4E B2RXH2 3/20 0.56
HSD17B10 Q99714 2/20 0.56
NPSR1 Q6W5P4 4/20 0.41
ALOX15 P16050 1/20 0.41
MAPT P10636 4/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
APP P05067 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
APAF1 O14727 1/20 0.39
ALOX12 P18054 1/20 0.39
CACNA1B Q00975 1/20 0.39
APBA1 Q02410 1/20 0.39
PDE4D Q08499 1/20 0.38
CA1 P00915 3/20 0.38
CA2 P00918 3/20 0.38
CA4 P22748 2/20 0.38
CA9 Q16790 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6470216 0.87 ALDH1A1 (0.53) ALDH1A1HPGDKDM4EHSD17B10MAPT
SCHEMBL6467658 0.86 ALDH1A1 (0.55) ALDH1A1HPGDKDM4EHSD17B10NPSR1
SCHEMBL6470262 0.83 KMT2A (0.36) ALDH1A1HPGDKDM4EHSD17B10MAPT
SCHEMBL6500282 0.81 ALDH1A1 (0.58) ALDH1A1HPGDKDM4EHSD17B10NPSR1
SCHEMBL6508436 0.80 ALDH1A1 (0.66) ALDH1A1HPGDKDM4EHSD17B10MAPT
SCHEMBL6470606 0.79 ALDH1A1 (0.56) ALDH1A1HPGDKDM4EHSD17B10MAPT
SCHEMBL6469895 0.77 ALDH1A1 (0.51) ALDH1A1HPGDKDM4EHSD17B10NPSR1
SCHEMBL6470677 0.75 HSD17B10 (0.43) ALDH1A1HPGDKDM4EHSD17B10MEN1
SCHEMBL6498775 0.75 KDM4E (0.51) ALDH1A1HPGDKDM4EHSD17B10MAPT
SCHEMBL6504869 0.73 ALDH1A1 (0.54) ALDH1A1HPGDKDM4EHSD17B10NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050197338-A1 Substituted pyrazole urea compounds for the treatment of inflammation PHARMACIA AND UPJOHN COMPANY LLC 2005-09-08 US disclosed
WO-2005037797-A1 SUBSTITUTED PYRAZOLE UREA COMPOUNDS FOR THE TREATMENT OF INFLAMMATION PHARMACIA CORPORATION (US) 2005-04-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050197338-A1 Substituted pyrazole urea compounds for the treatment of inflammation IL4, ARG2, CASP4 ALDH1A1 846/4885HPGD 1845/4885KDM4E 2424/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.